11.14.13
Jubilant HollisterStier has informed Theratechnologies, Inc. that a strike has been initiated by employees at its manufacturing site in Montreal, Canada. Jubilant is the third-party contract manufacturer for Theratechnologies tesamorelin, a synthetic form of growth-hormone used in the treatment of HIV-associated lipodystrophy.
According to Jubilant, its shipment of tesamorelin is still expected to resume by mid-December, regardless the strike. Theratechnologies is currently working with Jubilant management to minimize the consequences on the future manufacturing and shipment of tesamorelin and to minimize any disruption to patients.
According to Jubilant, its shipment of tesamorelin is still expected to resume by mid-December, regardless the strike. Theratechnologies is currently working with Jubilant management to minimize the consequences on the future manufacturing and shipment of tesamorelin and to minimize any disruption to patients.